Impact of adjuvant immunotherapy in resected stage II/III/IV melanoma: A single center experience

被引：0
|
作者：
Sevillano Tripero, Alberto Rafael
Ortiz, Carolina
Lostes, Julia
Bodet, Domingo
Ferrandiz, Carla
Bassas, Patricia
Chiquillo, Paula
Villacampa, Guillermo
Vega-Cano, Kreina Sharela
Garcia-Patos, Vicente
Recio, Juan
Munoz-Couselo, Eva
机构：
[1] Hosp Univ San Cecilio, Med Oncol Dept, Granada, Spain
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[4] Vall dHebron Hosp, Dermatol Dept, Barcelona, Spain
[5] Vall dHebron Hosp, Med Oncol Dept, Barcelona, Spain
[6] SOLTI Canc Res Grp, Barcelona, Spain
[7] Hosp Valle De Hebron, Barcelona, Spain
[8] Vall dHebron Univ Hosp HUVH, Med Oncol, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21565
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Management of resected stage III/IV melanoma with adjuvant immunotherapy.
    Johnson, Rebecca
    Atkinson, Victoria
    Bhave, Prachi
    Weppler, Alison Margaret
    Peters, Geoffrey David
    Abed, Afaf
    Lyle, Megan
    Khattak, Muhammad Adnan
    Haydon, Andrew Mark
    Carlino, Matteo S.
    Sandhu, Shahneen Kaur
    Long, Georgina V.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Adjuvant GM-CSF therapy for patients with resected stage III/IV melanoma: A retrospective review of a single-center experience.
    Markovic, S.
    Burch, P. A.
    LaPlant, B.
    Heun, J. M.
    Bradshaw, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
    Weber, J.
    Mandala, M.
    Del Vecchio, M.
    Gogas, H. J.
    Arance, A. M.
    Cowey, C. L.
    Dalle, S.
    Schenker, M.
    Chiarion-Sileni, V.
    Marquez-Rodas, I.
    Grob, J-J.
    Butler, M. O.
    Middleton, M. R.
    Maio, M.
    Atkinson, V.
    Queirolo, P.
    Gonzalez, R.
    Kudchadkar, R. R.
    Smylie, M.
    Meyer, N.
    Mortier, L.
    Atkins, M. B.
    Long, G. V.
    Bhatia, S.
    Lebbe, C.
    Rutkowski, P.
    Yokota, K.
    Yamazaki, N.
    Kim, T. M.
    de Pril, V.
    Sabater, J.
    Qureshi, A.
    Larkin, J.
    Ascierto, P. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19): : 1824 - 1835
  • [4] Adjuvant chemotherapy in stage II and III resected gastric cancer: clinical data from a single center experience
    Sauta, M. G.
    Squadroni, M.
    Brena, F.
    Bonomi, M.
    Ripa, C.
    Cerchiaro, E.
    Ceresoli, G. L.
    Salvini, P.
    Beretta, G.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [5] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Ridolfi, L
    Ridolfi, R
    Riccobon, A
    De Paola, F
    Petrini, M
    Stefanelli, M
    Flamini, E
    Ravaioli, A
    Verdecchia, GM
    Trevisan, G
    Amadori, D
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
  • [6] Adjuvant Pembrolizumab in Resected Stage III Melanoma
    Barker, Christopher A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 593 - 593
  • [7] Granulocyte macrophage colony stimulating factor as adjuvant therapy for resected stage III/IV melanoma: Retrospective review of a single institutional experience
    Patel, T. A.
    Baweja, M.
    Maples, W.
    Markovic, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study.
    Dima, Danai
    Lopetegui-Lia, Nerea
    Ogbue, Olisaemeka
    Osantowski, Bennett
    Ahmed, Ramsha
    Basali, Diana
    Chamseddine, Fatimah
    Eicher, Donald Matthew
    Song, Jung Min
    Gastman, Brian
    Kennedy, Lucy Boyce
    Funchain, Pauline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Impact of adjuvant immunotherapy on survival of patients with resected stage III melanoma diagnosed in 2003-2011 in the US
    Jang, S.
    Wang, H.
    Venna, S.
    [J]. MELANOMA RESEARCH, 2016, 26 : E8 - E9
  • [10] Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment
    Ann Livingstone
    Kirsten Howard
    Alexander M. Menzies
    Georgina V. Long
    Martin R. Stockler
    Rachael L. Morton
    [J]. The Patient - Patient-Centered Outcomes Research, 2023, 16 : 497 - 513
12345